Skip to main content
. 2007 Sep 15;65(3):347–354. doi: 10.1111/j.1365-2125.2007.03015.x

Table 3.

Renal excretion of (+)- and (−)-PHX at steady-state in five EM patients

Patient Dose recovered (%) (+)-PHX (−)-PHX: CLGF (ml h−1 kg−1) (+)-PHX (+)-PHX CLR (ml h−1 kg−1) (−)-PHX: CLR (−)-PHX CLR (+)-PHX
EM1 0.75 0.55 0.22 0.16 2.40 2.30 0.96
EM2 2.28 1.73 0.36 0.26 1.58 1.53 0.97
EM3 0.48 0.37 0.74 0.54 0.16 0.16 1.00
EM4 0.57 0.51 0.44 0.33 0.83 0.83 1.00
EM5 0.09 0.08 0.51 0.38 0.20 0.21 1.05
Mean 0.84 0.65 0.45 0.33 1.03 1.01 1.00
(95% CI) (−0.21, 1.88) (−0.14, 1.43) (0.21, 0.69) (0.16, 0.51) (−0.15, 2.22) (−0.13, 2.14) (0.95, 1.04)

PHX, Perhexiline. EM, extensive metabolizer.